IANS Advanced HRA Course

Preliminary Draft AGENDA


INTRODUCTION: DAY 1 Friday November 10th

12:00  Registration (will open at 10)

 1:00 Opening Remarks  (N. Jay)

 1:15  HPV Update: epidemiology of HPV in the anus and other sites – what’s new?(J. Palefsky)

 2:05  Pathology for the non-pathologist: HPV and the anus (T. Darragh)

 2:55  Q & A

 3:15  Coffee Break

 3:30  Panel: Assessment of the intra-anus: challenging situations      

    1. Advanced ABCs of HRA: improving lesion recognition (N. Jay)
    2. Worrisome HSIL or Cancer? (J. Berry)
    3. Diffuse presentation of HSIL and recurrent disease (S. Goldstone)

                       

 4:30  Workshop I
Case-based discussions on difficult intra-anal exams. Cases may include lesion recognition, distal canal disease, and management strategies. The 3rd half hour segment will be cases presented by attendees. Led by faculty (Jay, Berry, Goldstone, Palefsky)

                        Each group will attend 3 workshops - 30 minutes each

6:10  Adjourn

6:30  Optional: Meet & Greet with faculty and fellow attendees in hotel (location TBD)


DAY 2 Saturday November 11th

7:00 Breakfast (provided)

7:45  Dermatology of the Perianus (TBD)** 

8:30  Q&A

8:45 Advanced HRA of the perianus: recognizing HSIL and Cancer  (N. Jay)

  1. The complicated female patient (TBD)
  2. Treating perianal disease: different strategies (TBD)
  3. Under-treated, recurrent, or chronic recurrent disease (S. Goldstone)

10:40  Coffee Break

11:00  Workshop II
Case-based discussion on perianal disease. Cases may include recognition of perianal patterns, differential diagnosis and management of perianal disease. The 3rd half hour segment will be cases presented by attendees. Led by faculty (Jay, Berry, Goldstone, Palefsky)

                        Each group will attend 3 workshops - 30 minutes each                  

 12:40  Lunch Break (provided)

 1:30 Counseling the patient with anal cancer, HSIL, warts, HPV (TBD).

 2:15 Q&A

 2:25 Proctology: recognition and management of non-HPV anal disease (S. Goldstone)

 3:20 Q&A

 3:30 Coffee Break

 3:45 Panel: Treatment and Management Strategies

  1. Algorithms for treatment: patient-applied, office vs. surgical (J. Palefsky)
  2. Strategies for treatment of diffuse or multi-focal disease (M. Berry)
  3. Strategies for treatment of recurrent disease (S. Goldstone)

4:50  Workshop III
Case-based discussion on management strategies. Cases may include those that pose difficult treatment decisions, including diffuse, recurrent or multi-focal disease presentation.
The 3rd half hour segment will be cases presented by attendees. Led by faculty (Jay, Berry, Goldstone, Palefsky)

                        Each group will attend 3 workshops - 30 minutes each

6:30  Adjourn

  

DAY 3 Sunday November 12th

7:00  Breakfast (provided)

7:45  Anal cancer: new strategies for treatment and management (J. Berry)

8:30  Q&A

8:45   Panel: Management of the Patient with Anal Cancer (TBD)

  1. Metastatic and recurrent: what are the options (oncologist)
  2. Management of treatment related symptoms: (radiation oncologist)
  3. Post-cancer treatment management (S. Goldstone)

9:45  Up Close and Personal: perspectives of anal cancer survivors (TBD)

10:30  Q&A

10:45  Coffee Break

11:00  Workshops: Case-based discussion on management and workup of patients with anal cancer
Led by faculty (Jay, Berry, Goldstone, Palefsky)

            Each group will attend 4 workshops – 15 minutes each                             

12:00  Luncheon session: monitoring your progress: metrics to guide practice (TBD)

1:00    Wrap up

1:30     Adjourn

International Anal Neoplasia Society

PO Box 1543
Leesburg, Virginia 20177
Powered by Wild Apricot Membership Software